224 related articles for article (PubMed ID: 23762353)
21. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
[TBL] [Abstract][Full Text] [Related]
22. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.
Abe M; Ohira M; Kaneda A; Yagi Y; Yamamoto S; Kitano Y; Takato T; Nakagawara A; Ushijima T
Cancer Res; 2005 Feb; 65(3):828-34. PubMed ID: 15705880
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
24. CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.
Zhao X; Yang F; Li S; Liu M; Ying S; Jia X; Wang X
Br J Haematol; 2014 Jun; 165(5):649-58. PubMed ID: 24601943
[TBL] [Abstract][Full Text] [Related]
25. Unique DNA methylome profiles in CpG island methylator phenotype colon cancers.
Xu Y; Hu B; Choi AJ; Gopalan B; Lee BH; Kalady MF; Church JM; Ting AH
Genome Res; 2012 Feb; 22(2):283-91. PubMed ID: 21990380
[TBL] [Abstract][Full Text] [Related]
26. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
27. A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.
Kelly AD; Kroeger H; Yamazaki J; Taby R; Neumann F; Yu S; Lee JT; Patel B; Li Y; He R; Liang S; Lu Y; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Jelinek J; Issa JP
Leukemia; 2017 Oct; 31(10):2011-2019. PubMed ID: 28074068
[TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.
Nordlund J; Bäcklin CL; Wahlberg P; Busche S; Berglund EC; Eloranta ML; Flaegstad T; Forestier E; Frost BM; Harila-Saari A; Heyman M; Jónsson OG; Larsson R; Palle J; Rönnblom L; Schmiegelow K; Sinnett D; Söderhäll S; Pastinen T; Gustafsson MG; Lönnerholm G; Syvänen AC
Genome Biol; 2013 Sep; 14(9):r105. PubMed ID: 24063430
[TBL] [Abstract][Full Text] [Related]
30. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.
Sato H; Oka T; Shinnou Y; Kondo T; Washio K; Takano M; Takata K; Morito T; Huang X; Tamura M; Kitamura Y; Ohara N; Ouchida M; Ohshima K; Shimizu K; Tanimoto M; Takahashi K; Matsuoka M; Utsunomiya A; Yoshino T
Am J Pathol; 2010 Jan; 176(1):402-15. PubMed ID: 20019193
[TBL] [Abstract][Full Text] [Related]
31. Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes.
Tian Y; Arai E; Gotoh M; Komiyama M; Fujimoto H; Kanai Y
BMC Cancer; 2014 Oct; 14():772. PubMed ID: 25332168
[TBL] [Abstract][Full Text] [Related]
32. Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.
Roels J; Thénoz M; Szarzyńska B; Landfors M; De Coninck S; Demoen L; Provez L; Kuchmiy A; Strubbe S; Reunes L; Pieters T; Matthijssens F; Van Loocke W; Erarslan-Uysal B; Richter-Pechańska P; Declerck K; Lammens T; De Moerloose B; Deforce D; Van Nieuwerburgh F; Cheung LC; Kotecha RS; Mansour MR; Ghesquière B; Van Camp G; Berghe WV; Kowalczyk JR; Szczepański T; Davé UP; Kulozik AE; Goossens S; Curtis DJ; Taghon T; Dawidowska M; Degerman S; Van Vlierberghe P
Blood Cancer Discov; 2020 Nov; 1(3):274-289. PubMed ID: 33179015
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.
Milani L; Lundmark A; Kiialainen A; Nordlund J; Flaegstad T; Forestier E; Heyman M; Jonmundsson G; Kanerva J; Schmiegelow K; Söderhäll S; Gustafsson MG; Lönnerholm G; Syvänen AC
Blood; 2010 Feb; 115(6):1214-25. PubMed ID: 19965625
[TBL] [Abstract][Full Text] [Related]
34. Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas.
Abe M; Westermann F; Nakagawara A; Takato T; Schwab M; Ushijima T
Cancer Lett; 2007 Mar; 247(2):253-8. PubMed ID: 16759796
[TBL] [Abstract][Full Text] [Related]
35. Acute lymphoblastic leukemia displays a distinct highly methylated genome.
Hetzel S; Mattei AL; Kretzmer H; Qu C; Chen X; Fan Y; Wu G; Roberts KG; Luger S; Litzow M; Rowe J; Paietta E; Stock W; Mardis ER; Wilson RK; Downing JR; Mullighan CG; Meissner A
Nat Cancer; 2022 Jun; 3(6):768-782. PubMed ID: 35590059
[TBL] [Abstract][Full Text] [Related]
36. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
[TBL] [Abstract][Full Text] [Related]
37. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
[TBL] [Abstract][Full Text] [Related]
38. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
39. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW
Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078
[TBL] [Abstract][Full Text] [Related]
40. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.
Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S
Neoplasia; 2007 Dec; 9(12):1091-8. PubMed ID: 18084616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
